Assay Detail
Functional
CHEMBL4138352
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 72 hrs by SRB assay
12
Total Activities
12
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | Hep 3B2 |
| Confidence | 1 — Organism |
| Curated By | Intermediate |
Publication
Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 12 | 5.46 | 6.16 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL194176 | — | — | 1 | 6.16 |
| CHEMBL4164979 | — | — | 1 | 6.05 |
| CHEMBL1200485 | SORAFENIB TOSYLATE | 4.0 | 1 | 5.82 |
| CHEMBL3109274 | — | — | 1 | 5.70 |
| CHEMBL4165836 | — | — | 1 | 5.68 |
| CHEMBL4164325 | — | — | 1 | 5.37 |
| CHEMBL255682 | — | — | 1 | 5.30 |
| CHEMBL4160297 | — | — | 1 | 5.26 |
| CHEMBL4174446 | — | — | 1 | 5.00 |
| CHEMBL4170593 | — | — | 1 | 4.92 |
| CHEMBL4174979 | — | — | 1 | 4.76 |
| CHEMBL4164116 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL194176 | — | IC50 | = | 700.0 | nM | 6.16 |
| CHEMBL4164979 | — | IC50 | = | 900.0 | nM | 6.05 |
| CHEMBL1200485 | SORAFENIB TOSYLATE | IC50 | = | 1500.0 | nM | 5.82 |
| CHEMBL3109274 | — | IC50 | = | 2000.0 | nM | 5.70 |
| CHEMBL4165836 | — | IC50 | = | 2100.0 | nM | 5.68 |
| CHEMBL4164325 | — | IC50 | = | 4300.0 | nM | 5.37 |
| CHEMBL255682 | — | IC50 | = | 5000.0 | nM | 5.30 |
| CHEMBL4160297 | — | IC50 | = | 5500.0 | nM | 5.26 |
| CHEMBL4174446 | — | IC50 | = | 9900.0 | nM | 5.00 |
| CHEMBL4170593 | — | IC50 | = | 12000.0 | nM | 4.92 |
| CHEMBL4174979 | — | IC50 | = | 17400.0 | nM | 4.76 |
| CHEMBL4164116 | — | IC50 | - | — | - |